![Rick Pollack, American Hospital Association CEO and President standing in front of United States flag and the AHA seal.](/sites/default/files/2022-04/AT-Rick-Pollack-Perspective-2022-News-900x400.jpg)
The Senate last night voted 98-2 to approve the Patient Right to Know Drug Prices Act (S. 2554), a bill that would prohibit private health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance.